Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 10, 2013, Pages 1451-1462

  Vučen, Sonja R ^a,b   Vuleta, Gordana ^c   Crean, Abina M ^a   Moore, Anne C ^a   Ignjatovic̈, Nenad ^d   Uskokovic̈, Dragan ^d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF BANJA LUKA   (Bosnia and Herzegovina)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d INSTITUTE OF TECHNICAL SCIENCES   (Serbia)

Author keywords

ketoprofen; microneedles; nanoparticles; skin

Indexed keywords

KETOPROFEN; NANOCARRIER; POLYLACTIC ACID; SILICON;

ANIMAL TISSUE; ARTICLE; COMPOSITE MATERIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; EQUIPMENT DESIGN; IN VITRO STUDY; ISOLATED ORGAN; ISOLATED SKIN; MICRONEEDLE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; SKIN PERMEABILITY; SURFACE PROPERTY; TEMPERATURE SENSITIVITY;

KETOPROFEN; MICRONEEDLES; NANOPARTICLES; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIFFUSION CHAMBERS, CULTURE; DRUG CARRIERS; DRUG COMPOUNDING; KETOPROFEN; MICROSCOPY, ELECTROCHEMICAL, SCANNING; NANOPARTICLES; NEEDLES; PARTICLE SIZE; PERMEABILITY; SILICON; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES; SWINE;

EID: 84883741603     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12118     Document Type: Article

References (62)

1. Torchilin VP,. Nanoparticulates As Drug Carriers. Singapore: Imperial College Press, 2006.
2. Rancan F, et al. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res 2009; 8: 2027-2036.
3. Zhang W, et al. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm 2010; 1-2: 205-212.
4. Feng SS, Huang GF,. Effects of emulsifiers on the controlled release of paclitaxel (Taxol (R)) from nanospheres of biodegradable polymers. J Control Release 2001; 1: 53-69.
5. Sanchez A, et al. Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A. Int J Pharm 1993; 2: 263-273.
6. Teixeira M, et al. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm 2005; 3: 491-500.
7. Couvreur P, et al. Controlled drug delivery with nanoparticles-current possibilities and future trends. Eur J Pharm Biopharm 1995; 1: 2-13.
8. Lowe JP, Temple SC,. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J Pharm Pharmacol 1994; 7: 547-552.
9. Couvreur P, et al. Intracellular targeting of antibiotics by means of biodegradable nanoparticles. J Control Release 1992; 1: 259-267.
10. Fonseca C, et al. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 2002; 2: 273-286.
11. Vonkeman HE, van de Laar MAFJ,. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum 2010; 4: 294-312.
12. Heyneman CA, et al. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 2000; 3: 555-574.
13. Banga AK,. Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies. Boca Raton, FL: CRC Press, Taylor & Francis Group, 2011.
14. Kim BS, et al. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv 2008; 7: 465-469.
15. Valenta C, Almasiszabo I,. In-vitro diffusion studies of ketoprofen transdermal therapeutic systems. Drug Dev Ind Pharm 1995; 15: 1799-1805.
16. Paolino D, et al. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 2002; 1-2: 21-31.
17. Shah P, et al. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Release 2012; 158: 336-345.
18. Hadgraft J,. Skin deep. Eur J Pharm Biopharm 2004; 2: 291-299.
19. Kalia YN, Guy RH,. Modeling transdermal drug release. Adv Drug Deliv Rev 2001; 2-3: 159-172.
20. Guterres SS, et al. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2007; 2: 147-157.
21. Hadgraft J, et al. The selection of non-steroidal anti-inflammatory agents for dermal delivery. Int J Pharm 2000; 1: 31-37.
22. Sodergard A, Stolt M,. Properties of lactic acid based polymers and their correlation with composition. Prog Polym Sci 2002; 6: 1123-1163.
23. Liu MX, et al. Characterization and release of triptolide-loaded poly (D,L-lactic acid) nanoparticles. Eur Polym J 2005; 2: 375-382.
24. Carey JB, et al. Microneedle array design determines the induction of protective memory CD8(+) T cell responses induced by a recombinant live malaria vaccine in mice. PLoS ONE 2011; 7: e22442.
25. Vrdoljak A, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012; 1: 34-42.
26. Henry S, et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998; 8: 922-925.
27. Gardeniers HJGE, et al. Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Syst 2003; 6: 855-862.
28. Qiu Y, et al. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 2008; 2: 144-150.
29. Gomaa YA, et al. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol 2012; 11: 1592-1602.
30. Alvarez-Román R, et al. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004; 1: 53-62.
31. Fessi C, et al. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent 5,118,528, 1992.
32. Mitranic I, et al. Controllable synthesis of horseradish peroxidase loaded poly (D, L-lactide) nanospheres. J Bionanosci 2009; 3: 1-11.
33. British Pharmacopoeia Commission. British Pharmacopoeia. London: The Stationary Office, 2009.
34. Trimaille T, et al. Poly(D,L-lactic acid) nanoparticle preparation and colloidal characterization. Colloid Polym Sci 2003; 12: 1184-1190.
35. Malvern Instruments Limited. Mastersizer 2000 Integrated systems for particle sizing [Broshure]. 2012.
36. Costa P, Sousa Lobo JM,. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 2: 123-133.
37. Williams A,. Transdermal and Topical Drug Delivery from Theory to Clinical Practice. London: Pharmaceutical Press, 2003.
38. Vettor M, et al. Skin absorption studies of octyl-methoxycinnamate loaded poly(D,L-lactide) nanoparticles: estimation of the UV filter distribution and release behaviour in skin layers. J Microencapsul 2010; 3: 253-262.
39. Gallagher S, Heard C,. Solvent content and macroviscosity effects on the in vitro transcutaneous delivery and skin distribution of ketoprofen from simple gel formulations. Skin Pharmacol Physiol 2005; 4: 186-194.
40. Ricci M, et al. Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post-transplant acute inflammation. J Control Release 2005; 3: 395-407.
41. Barichello JM, et al. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm 1999; 4: 471-476.
42. Jelvehgari M, et al. Preparation and evaluation of Poly (ε-caprolactone) nanoparticles-in-microparticles by W/O/W emulsion method. Iran J Basic Med Sci 2010; 13: 85-96.
43. Del Gaudio P, et al. Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release. AAPS PharmSciTech 2009; 4: 1178-1185.
44. QuintanarGuerrero D, et al. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 1996; 2: 133-141.
45. Jovanovic I, et al. Preparation of smallest microparticles of poly-D,L-lactide by modified precipitation method: influence of the process parameters. Microsc Res Tech 2008; 2: 86-92.
46. Freitas MN, Marchetti JM,. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharm 2005; 1-2: 201-211.
47. Teixeira Z, et al. Retinyl palmitate flexible polymeric nanocapsules: Characterization and permeation studies. Colloids Surf B Biointerfaces 2010; 1: 374-380.
48. Sheihet L, et al. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int J Pharm 2008; 1: 312-319.
49. Milicevic D, et al. The influence of gamma radiation on the molecular weight and glass transition of PLLA and HAp/PLLA nanocomposite. Nucl Instrum Meth Phys Res B 2010; 268: 2744-2749.
50. Fox TG, Flory PJ,. Viscosity-molecular weight and viscosity-temperature relationships for polystyrene and polyisobutylene. J Am Chem Soc 1948; 7: 2384-2395.
51. Qian RY, et al. Single-chain polystirene glasses. Macromolecules 1993; 11: 2950-2953.
52. Liao KR, et al. Effects of physical aging on glass transition behavior of poly(DL-lactide). Eur Polym J 2002; 1: 157-162.
53. Zhou Q, Xanthos M,. Nanosize and microsize clay effects on the kinetics of the thermal degradation of polylactides. Polym Degr Stab 2009; 94: 327-338.
54. Mello VA, Ricci-Júnior E,. Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies. Quim Nova 2011; 34: 933-939.
55. Corrigan OI, Li X,. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci 2009; 3-4: 477-485.
56. Korsmeyer RW, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 1: 25-35.
57. Kosmidis K, et al. Analysis of Case II drug transport with radial and axial release from cylinders. Int J Pharm 2003; 2: 183-188.
58. Mohanraj V, Chen Y,. Nanoparticles-a review. Trop J Pharm Res 2007; 1: 561-573.
59. Patlolla RR, et al. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 2010; 21: 5598-5607.
60. Zaric M, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen encapsulated poly-DL-lactide-co-glycolide nanoparticles induces efficient anti-tumour and anti-viral immune responses. ACS nano 2013; 7: 2042-2055.
61. Nair HB, et al. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010; 12: 1833-1843.
62. Fadeel B, Garcia-Bennett AE,. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010; 3: 362-374